Reissmann K, Fickert U, Schirmer R
Z Gesamte Inn Med. 1980 Nov 15;35(22):812-5.
It is reported on own results and experiences in 53 thrombolyses with the streptokinase preparation Awelysin. In the greater part of the 46 patients with phlebothrombosis the cases in question were late thromboses (n = 32). In 7 cases an arterial lysis was performed. The author enters in detail the questions of dosage and side-effects as well as complications. By reason of the phlebographic and clinical findings before and after therapy also in older thromboses may be still reckoned with complete or extensive recanalisation in 65.5% and with a clinical symptom-free state in 71%. In comparison to reports on results in early lysis the findings got do not show essential deviations in late lysis.
本文报道了使用链激酶制剂Awelysin进行53例溶栓治疗的自身结果和经验。在46例静脉血栓形成患者中，大部分病例为晚期血栓形成（n = 32）。进行了7例动脉溶栓。作者详细阐述了剂量、副作用及并发症等问题。根据治疗前后的静脉造影和临床结果，即使是陈旧性血栓，仍有65.5%的病例可能实现完全或广泛再通，71%的病例临床症状消失。与早期溶栓结果的报道相比，晚期溶栓的结果并无本质差异。
